Open access
105
Views
0
CrossRef citations to date
0
Altmetric
REVIEW
Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials
Robin Imperial1 Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL, USA
, Osama Mosalem1 Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL, USAhttps://orcid.org/0000-0002-3779-185X
, Umair Majeed1 Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL, USA
, Nguyen H Tran2 Department of Medical Oncology, Rochester, MN, USA
, Mitesh J Borad3 Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA
& Hani Babiker1 Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL, USACorrespondence[email protected]
Pages 121-134
|
Received 16 Sep 2023, Accepted 11 Apr 2024, Published online: 17 Apr 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.